Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ott

Showing results (181-190 of 419) with videos related to

Pageof 42
Sort By:
Neurology|August 1, 1993
Human herpesvirus-6 and Epstein-Barr virus genome in primary cerebral lymphomasW Paulus, K Jellinger, C Hallas, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|May 1, 1987
Cohort mortality study of chemical workers with potential exposure to the higher chlorinated dioxinsM G Ott, R A Olson, R R Cook, et al.
The European Respiratory Journal|January 1, 1996
Pulmonary sarcoidosis: patterns of cytokine release in vitroC Prior, R A Knight, M Herold, et al.
Gynecologic Oncology|October 20, 1999
Radiopharmaceutical-guided surgery in primary malignant melanoma of the vaginaJ F Rodier, J C Janser, E David, et al.
American Industrial Hygiene Association Journal|October 1, 1975
Linking industrial hygiene and health recordsM G Ott, H R Hoyle, R R Langner, et al.
Cytometry|May 14, 1998
Differentiation of low-grade non-Hodgkin's lymphomas using paraffin sections by image processingS Kneitz, G Ott, R Albert, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 13, 2007
[Pfeifer-Weber-Christian syndrome associated with Kikuchi syndrome in infliximab therapy: development of necrotizing allergic vasculitis]B Belloni, C Andres, G Ott, et al.
Biochimie|July 1, 1991
How many EF-Tu molecules participate in aminoacyl-tRNA binding?K Bensch, U Pieper, G Ott, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1996
Peripheral natural killer cell activity and intraperitoneal soluble p55 tumor necrosis factor receptor in patients with malignant ascites: two possible indicators for response to intraperitoneal combined tumor necrosis factor alpha and interferon gamma treatmentM G Ott, D N Männel, H Gallati, et al.
British Journal of Industrial Medicine|August 1, 1983
Medical and morbidity surveillance findings among employees potentially exposed to TCDDG G Bond, M G Ott, F E Brenner, et al.
Pageof 42

Showing results (181-190 of 419) with videos related to

Sort By:
Pageof 42
Neurology|August 1, 1993
Human herpesvirus-6 and Epstein-Barr virus genome in primary cerebral lymphomasW Paulus, K Jellinger, C Hallas, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|May 1, 1987
Cohort mortality study of chemical workers with potential exposure to the higher chlorinated dioxinsM G Ott, R A Olson, R R Cook, et al.
The European Respiratory Journal|January 1, 1996
Pulmonary sarcoidosis: patterns of cytokine release in vitroC Prior, R A Knight, M Herold, et al.
Gynecologic Oncology|October 20, 1999
Radiopharmaceutical-guided surgery in primary malignant melanoma of the vaginaJ F Rodier, J C Janser, E David, et al.
American Industrial Hygiene Association Journal|October 1, 1975
Linking industrial hygiene and health recordsM G Ott, H R Hoyle, R R Langner, et al.
Cytometry|May 14, 1998
Differentiation of low-grade non-Hodgkin's lymphomas using paraffin sections by image processingS Kneitz, G Ott, R Albert, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 13, 2007
[Pfeifer-Weber-Christian syndrome associated with Kikuchi syndrome in infliximab therapy: development of necrotizing allergic vasculitis]B Belloni, C Andres, G Ott, et al.
Biochimie|July 1, 1991
How many EF-Tu molecules participate in aminoacyl-tRNA binding?K Bensch, U Pieper, G Ott, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1996
Peripheral natural killer cell activity and intraperitoneal soluble p55 tumor necrosis factor receptor in patients with malignant ascites: two possible indicators for response to intraperitoneal combined tumor necrosis factor alpha and interferon gamma treatmentM G Ott, D N Männel, H Gallati, et al.
British Journal of Industrial Medicine|August 1, 1983
Medical and morbidity surveillance findings among employees potentially exposed to TCDDG G Bond, M G Ott, F E Brenner, et al.
Pageof 42